MA50517A - Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole - Google Patents
Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrroleInfo
- Publication number
- MA50517A MA50517A MA050517A MA50517A MA50517A MA 50517 A MA50517 A MA 50517A MA 050517 A MA050517 A MA 050517A MA 50517 A MA50517 A MA 50517A MA 50517 A MA50517 A MA 50517A
- Authority
- MA
- Morocco
- Prior art keywords
- preparation process
- intermediate preparation
- derivative intermediate
- methoxypyrrole derivative
- methoxypyrrole
- Prior art date
Links
- OTODBDQJLMYYKQ-UHFFFAOYSA-N 3-methoxy-1h-pyrrole Chemical class COC=1C=CNC=1 OTODBDQJLMYYKQ-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170067646A KR102233456B1 (ko) | 2017-05-31 | 2017-05-31 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50517A true MA50517A (fr) | 2020-09-09 |
Family
ID=64456008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050517A MA50517A (fr) | 2017-05-31 | 2018-05-31 | Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10710961B2 (fr) |
| EP (2) | EP4219448A1 (fr) |
| JP (1) | JP6799177B2 (fr) |
| KR (1) | KR102233456B1 (fr) |
| CN (1) | CN110637009B (fr) |
| AU (1) | AU2018278731B2 (fr) |
| CA (1) | CA3061708C (fr) |
| CL (1) | CL2019003449A1 (fr) |
| CO (1) | CO2019012686A2 (fr) |
| DO (1) | DOP2019000292A (fr) |
| EC (1) | ECSP19081839A (fr) |
| JO (1) | JOP20190264B1 (fr) |
| MA (1) | MA50517A (fr) |
| MX (1) | MX394299B (fr) |
| MY (1) | MY193162A (fr) |
| NZ (1) | NZ758743A (fr) |
| PE (1) | PE20200399A1 (fr) |
| PH (1) | PH12019502638A1 (fr) |
| RU (1) | RU2718920C1 (fr) |
| SA (1) | SA519410408B1 (fr) |
| TN (1) | TN2019000300A1 (fr) |
| WO (1) | WO2018221971A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
| KR102233455B1 (ko) * | 2017-06-21 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| KR102126576B1 (ko) | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| WO2022051979A1 (fr) * | 2020-09-10 | 2022-03-17 | 广东莱佛士制药技术有限公司 | Procédé de préparation d'intermédiaire de bloqueur compétitif d'ions de potassium |
| CN112094219B (zh) * | 2020-09-10 | 2022-08-05 | 广东莱佛士制药技术有限公司 | 一种制备钾离子竞争性阻滞剂中间体的方法 |
| CN116693442A (zh) * | 2023-04-28 | 2023-09-05 | 诚达药业股份有限公司 | 一种4-甲氧基吡咯衍生物及其合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622948A (en) | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
| KR100286874B1 (ko) * | 1998-03-04 | 2001-04-16 | 성재갑 | 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법 |
| DK1784404T3 (da) * | 2004-09-03 | 2012-02-13 | Yuhan Corp | Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling |
| EP2336107B1 (fr) | 2004-09-30 | 2015-09-23 | Takeda Pharmaceutical Company Limited | Inhibiteurs de pompe a protons |
| DE102004053191A1 (de) | 2004-11-04 | 2006-05-11 | Bayer Cropscience Ag | 2,6-Diethyl-4-methyl-phenyl substituierte Tetramsäure-Derivate |
| BR122020004679B1 (pt) * | 2005-12-19 | 2021-09-21 | Raqualia Pharma Inc | Composição farmacêutica |
| CN104718189B (zh) * | 2012-11-19 | 2017-03-15 | 江苏豪森药业集团有限公司 | 吡咯磺酰类衍生物、其制备方法及其在医药上的应用 |
| KR101613245B1 (ko) | 2015-04-27 | 2016-04-18 | 주식회사 대웅제약 | 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
-
2017
- 2017-05-31 KR KR1020170067646A patent/KR102233456B1/ko active Active
-
2018
- 2018-05-31 EP EP23165218.1A patent/EP4219448A1/fr active Pending
- 2018-05-31 CN CN201880029533.9A patent/CN110637009B/zh active Active
- 2018-05-31 MX MX2019014323A patent/MX394299B/es unknown
- 2018-05-31 AU AU2018278731A patent/AU2018278731B2/en active Active
- 2018-05-31 EP EP18809178.9A patent/EP3630722A4/fr not_active Ceased
- 2018-05-31 RU RU2019135240A patent/RU2718920C1/ru active
- 2018-05-31 MY MYPI2019006879A patent/MY193162A/en unknown
- 2018-05-31 US US16/608,910 patent/US10710961B2/en active Active
- 2018-05-31 NZ NZ758743A patent/NZ758743A/en unknown
- 2018-05-31 MA MA050517A patent/MA50517A/fr unknown
- 2018-05-31 PE PE2019002401A patent/PE20200399A1/es unknown
- 2018-05-31 TN TNP/2019/000300A patent/TN2019000300A1/en unknown
- 2018-05-31 WO PCT/KR2018/006188 patent/WO2018221971A1/fr not_active Ceased
- 2018-05-31 JP JP2019561188A patent/JP6799177B2/ja active Active
- 2018-05-31 CA CA3061708A patent/CA3061708C/fr active Active
-
2019
- 2019-10-29 SA SA519410408A patent/SA519410408B1/ar unknown
- 2019-11-12 JO JOJO/P/2019/0264A patent/JOP20190264B1/ar active
- 2019-11-14 DO DO2019000292A patent/DOP2019000292A/es unknown
- 2019-11-14 CO CONC2019/0012686A patent/CO2019012686A2/es unknown
- 2019-11-15 EC ECSENADI201981839A patent/ECSP19081839A/es unknown
- 2019-11-22 PH PH12019502638A patent/PH12019502638A1/en unknown
- 2019-11-26 CL CL2019003449A patent/CL2019003449A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2019012686A2 (es) | 2020-04-01 |
| MX394299B (es) | 2025-03-21 |
| CN110637009B (zh) | 2023-11-10 |
| EP3630722A1 (fr) | 2020-04-08 |
| CA3061708A1 (fr) | 2018-12-06 |
| SA519410408B1 (ar) | 2021-10-21 |
| JOP20190264B1 (ar) | 2025-10-01 |
| MX2019014323A (es) | 2020-02-10 |
| BR112019024976A2 (pt) | 2020-06-23 |
| WO2018221971A1 (fr) | 2018-12-06 |
| EP4219448A1 (fr) | 2023-08-02 |
| US10710961B2 (en) | 2020-07-14 |
| JP6799177B2 (ja) | 2020-12-09 |
| PE20200399A1 (es) | 2020-02-26 |
| TN2019000300A1 (en) | 2021-05-07 |
| CA3061708C (fr) | 2021-06-22 |
| PH12019502638A1 (en) | 2020-07-13 |
| EP3630722A4 (fr) | 2020-10-21 |
| NZ758743A (en) | 2022-07-29 |
| KR20180131081A (ko) | 2018-12-10 |
| US20200181079A1 (en) | 2020-06-11 |
| CN110637009A (zh) | 2019-12-31 |
| RU2718920C1 (ru) | 2020-04-15 |
| AU2018278731A1 (en) | 2019-11-21 |
| KR102233456B1 (ko) | 2021-03-29 |
| JP2020518647A (ja) | 2020-06-25 |
| AU2018278731B2 (en) | 2021-02-18 |
| MY193162A (en) | 2022-09-26 |
| DOP2019000292A (es) | 2019-12-15 |
| ECSP19081839A (es) | 2019-11-30 |
| JOP20190264A1 (ar) | 2019-11-12 |
| CL2019003449A1 (es) | 2020-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3677589A4 (fr) | Procédé amélioré de production d'un conjugué anticorps-médicament | |
| MA49472A (fr) | Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole | |
| EP3398960A4 (fr) | Procédé de préparation du sermaglutide | |
| MA52906A (fr) | Procédé de préparation d'amg 416 | |
| EP3349772A4 (fr) | Procédé de préparation d'extraits d'herbes | |
| EP3733650A4 (fr) | Procédé de préparation d'un intermédiaire d'élagolix et composition associée | |
| EP3556769A4 (fr) | Dérivé de polyximine, procédé de préparation et application associés | |
| EP3597674A4 (fr) | Procédé de préparation de copolymère | |
| EP3412665A4 (fr) | Intermédiaire de suvorexant et son procédé de préparation | |
| EP3695433A4 (fr) | Procédé de préparation d'échantillon de section transversale | |
| EP3766869A4 (fr) | Procédé simple de préparation d'avibactam | |
| EP3372596A4 (fr) | Procédé de préparation de tédizolide, intermédiaire de tédizolide et procédé pour sa préparation | |
| EP3694499A4 (fr) | Nouveau procédé de préparation de lifitegrast | |
| MA42423A (fr) | Procédé de préparation d'un revêtement | |
| EP3323297A4 (fr) | Procédé de stérilisation de sauce d'assaisonnement | |
| EP3696168A4 (fr) | Procédé de préparation de 2-chloro-5-trifluorométhylpyridine | |
| EP3539941A4 (fr) | Procédé de préparation triméthylolpropane | |
| EP3406619A4 (fr) | Procédé et intermédiaire pour la préparation de la tulathromycine | |
| EP3647304A4 (fr) | Procédé de préparation de 2-fluoroacrylate | |
| EP3505525A4 (fr) | Procédé de préparation de rubusoside | |
| EP3365332A4 (fr) | Procédé de préparation d'intermédiaire pour dérivé d'oxazolidinone | |
| EP3733651A4 (fr) | Procédé de préparation de calcobutrol | |
| EP3543236A4 (fr) | Procédé de préparation d'un intermédiaire d'avibactam | |
| EP3770239A4 (fr) | Procédé de préparation de microcapsules | |
| EP3666756A4 (fr) | Procédé de préparation de lévétiracétam |